Tomas Norling

Title: The Innovations of Tomas Norling

Introduction

Tomas Norling is a notable inventor based in Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral dosage forms. His work focuses on improving the bioavailability and pharmacokinetic parameters of medications.

Latest Patents

Tomas Norling's latest patents include a once daily oral dosage form comprising tacrolimus. This extended release oral dosage form is designed for immunosuppressive treatment, allowing for a consistent release of the active substance over an extended period. The formulation ensures that at most 63.5% of the active substance is released at the 12-hour mark, as defined by in vitro dissolution tests. Additionally, he has developed solid dispersions comprising tacrolimus, which enhance bioavailability through the use of hydrophilic or water-miscible vehicles.

Career Highlights

Throughout his career, Tomas Norling has worked with prominent companies in the pharmaceutical industry. He has been associated with Veloxis Pharmaceuticals A/S and Lifecycle Pharma A/S, where he has contributed to innovative drug formulations and delivery systems.

Collaborations

Tomas has collaborated with several professionals in his field, including Per Holm and Anne-Marie Lademann. Their combined expertise has likely contributed to the advancements in the pharmaceutical formulations they have worked on together.

Conclusion

Tomas Norling's work in the pharmaceutical industry showcases his dedication to innovation and improving patient care through advanced drug delivery systems. His contributions are significant in the realm of oral dosage forms, particularly in enhancing the effectiveness of tacrolimus.